Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia

Background: Erythropoiesis-stimulating agents (ESAs) are used to treat refractory anemia (RA). Guidelines suggest iron supplementation for unresponsive patients, regardless of iron deficiency. The primary aim of this study was to evaluate the effect of iron supplementation with ferric carboxymaltose...

Descripción completa

Detalles Bibliográficos
Autores principales: Gidaro, Antonio, Delitala, Alessandro Palmerio, Berzuini, Alessandra, Soloski, Mark J., Manca, Pietro, Castro, Dante, Salvi, Emanuele, Manetti, Roberto, Lambertenghi Deliliers, Giorgio, Castelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410338/
https://www.ncbi.nlm.nih.gov/pubmed/36012983
http://dx.doi.org/10.3390/jcm11164744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410338/
https://www.ncbi.nlm.nih.gov/pubmed/36012983
http://dx.doi.org/10.3390/jcm11164744

Ejemplares similares